Operating Profit Margin
since 2005
Calculation
Vertex Pharmaceuticals Inc., operating profit margin, long-term trends, calculation
| Operating profit margin | = | 100 | × | Income (loss) from operations1 | ÷ | Revenues1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2023 | 38.83% | = | 100 | × | 3,832,000) | ÷ | 9,869,200) |
| Dec 31, 2022 | 48.23% | = | 100 | × | 4,307,400) | ÷ | 8,930,700) |
| Dec 31, 2021 | 36.73% | = | 100 | × | 2,782,100) | ÷ | 7,574,400) |
| Dec 31, 2020 | 46.03% | = | 100 | × | 2,856,290) | ÷ | 6,205,683) |
| Dec 31, 2019 | 28.77% | = | 100 | × | 1,197,566) | ÷ | 4,162,821) |
| Dec 31, 2018 | 20.84% | = | 100 | × | 635,150) | ÷ | 3,047,597) |
| Dec 31, 2017 | 4.95% | = | 100 | × | 123,243) | ÷ | 2,488,652) |
| Dec 31, 2016 | 0.58% | = | 100 | × | 9,936) | ÷ | 1,702,177) |
| Dec 31, 2015 | -45.23% | = | 100 | × | (466,879) | ÷ | 1,032,336) |
| Dec 31, 2014 | -119.30% | = | 100 | × | (692,412) | ÷ | 580,415) |
| Dec 31, 2013 | -74.54% | = | 100 | × | (903,448) | ÷ | 1,211,975) |
| Dec 31, 2012 | 0.15% | = | 100 | × | 2,332) | ÷ | 1,527,042) |
| Dec 31, 2011 | 8.07% | = | 100 | × | 113,820) | ÷ | 1,410,626) |
| Dec 31, 2010 | -485.51% | = | 100 | × | (696,077) | ÷ | 143,370) |
| Dec 31, 2009 | -602.63% | = | 100 | × | (614,012) | ÷ | 101,889) |
| Dec 31, 2008 | -263.65% | = | 100 | × | (462,708) | ÷ | 175,504) |
| Dec 31, 2007 | -210.94% | = | 100 | × | (419,792) | ÷ | 199,012) |
| Dec 31, 2006 | -105.86% | = | 100 | × | (229,038) | ÷ | 216,356) |
| Dec 31, 2005 | -93.15% | = | 100 | × | (149,872) | ÷ | 160,890) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in thousands
Comparison to Competitors
Vertex Pharmaceuticals Inc., operating profit margin, long-term trends, comparison to competitors
| Vertex Pharmaceuticals Inc. | AbbVie Inc. | Amgen Inc. | Danaher Corp. | Gilead Sciences Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2023 | 38.83% | 23.49% | 29.35% | 21.77% | 28.24% | 30.85% | 16.00% |
| Dec 31, 2022 | 48.23% | 31.21% | 38.57% | 27.61% | 27.17% | 38.93% | 18.69% |
| Dec 31, 2021 | 36.73% | 31.89% | 31.44% | 25.35% | 36.72% | 55.67% | 25.57% |
| Dec 31, 2020 | 46.03% | 24.81% | 37.70% | 18.99% | 16.72% | 42.09% | 24.19% |
| Dec 31, 2019 | 28.77% | 39.03% | 43.57% | 18.25% | 19.38% | 28.10% | 17.99% |
| Dec 31, 2018 | 20.84% | 19.49% | 45.55% | 17.11% | 37.83% | 37.77% | 15.53% |
| Dec 31, 2017 | 4.95% | 33.99% | 45.76% | 16.48% | 55.04% | 35.41% | 14.19% |
| Dec 31, 2016 | 0.58% | 36.60% | 44.74% | 16.29% | 58.87% | 27.38% | 13.40% |
| Dec 31, 2015 | -45.23% | 32.97% | 40.44% | 16.87% | 69.03% | 30.51% | 13.77% |
| Dec 31, 2014 | -119.30% | 17.09% | 32.03% | 17.23% | 62.37% | 29.74% | 14.82% |
| Dec 31, 2013 | -74.54% | 30.14% | 32.25% | 17.13% | 41.87% | 36.11% | 12.30% |
| Dec 31, 2012 | 0.15% | 31.65% | 33.52% | 17.33% | 42.67% | 33.20% | 11.85% |
| Dec 31, 2011 | 8.07% | — | 28.19% | 16.27% | 46.77% | -46.02% | 10.62% |
| Dec 31, 2010 | -485.51% | — | 37.82% | 16.41% | 53.62% | -21.23% | 11.72% |
| Dec 31, 2009 | -602.63% | — | 38.37% | 13.79% | 54.55% | -19.54% | 10.38% |
| Dec 31, 2008 | -263.65% | — | 35.50% | 14.72% | 52.68% | -37.67% | 11.71% |
| Dec 31, 2007 | -210.94% | — | 27.81% | 15.79% | 57.98% | -91.55% | 10.00% |
| Dec 31, 2006 | -105.86% | — | 27.71% | 15.82% | -29.32% | -169.68% | 6.38% |
| Dec 31, 2005 | -93.15% | — | 40.33% | 15.84% | 61.41% | -187.97% | 10.01% |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).